INTELLIA THERAPEUTICS, INC. (NTLA) Operating cash flow 2016–2025
INTELLIA THERAPEUTICS, INC. (NTLA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$394.7MFY2025 · since FY2016: $36.1M → -$394.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$394.7M | -13.1% |
| FY2024 | -$348.9M | +11.5% |
| FY2023 | -$394.1M | -18.2% |
| FY2022 | -$333.3M | -48.1% |
| FY2021 | -$225.0M | -350.9% |
| FY2020 | -$49.9M | +51.7% |
| FY2019 | -$103.2M | -68.5% |
| FY2018 | -$61.3M | +6.2% |
| FY2017 | -$65.3M | -280.8% |
| FY2016 | $36.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice